GLP-1 Cost in 2026: What You'll Really Pay Per Month

Direct answer: Cash-pay GLP-1 programs in the US typically run $99 to $348 a month in 2026, and almost all of them increase as your dose goes up. Branded GLP-1 medications list well above that without insurance — Ozempic® from about $1,392/mo, Mounjaro® from $1,505/mo, Zepbound® from $1,512/mo, and Wegovy® from $1,856/mo.

The GLP Doctor's compounded weight loss programs start considerably lower — $149/month for semaglutide, $199/month for tirzepatide, and $259/month for semaglutide oral tablets — with pricing that stays flat regardless of dose. Insurance, where it's available, changes the number entirely and is the cheapest route when it applies.

Why the Advertised Price Isn't the Price You'll Pay

Look closely at how most GLP-1 offers are written. The number in the ad is almost always the entry dose, month one, sometimes with an introductory discount folded in. It's a real price — it just isn't the price you'll be paying by month six.

That's not inherently deceptive. Dose-based pricing is a normal way to sell a drug that costs more to supply at higher strengths. The problem is that most people compare programs using a number that describes month one, then live with a different number for the rest of the year.

How Much Does Semaglutide Cost Per Month in 2026?

For cash-pay telehealth, the honest answer is a range, not a single figure: roughly $99 to $348 a month, depending on the provider, the dose, and what's bundled in. Four payment routes sit behind that range, and they behave very differently.

• Insurance: copay only if covered, depending on plan formulary, prior authorization, and employer benefit design. The catch — coverage for weight management is inconsistent, and some employers have dropped it.
• Manufacturer self-pay: check the manufacturer's current program page; depends on the product, dose, and eligibility rules. The catch — self-pay terms change, so verify on the day you enroll.
• Telehealth cash-pay: roughly $99–$348 a month, depending on the provider, dose tier, and add-on fees. The catch — most tiers rise as your dose increases.
• 503A compounded: varies by pharmacy and provider, and requires an individualized clinical reason documented by your prescriber. The catch — not FDA-approved, and not reviewed by FDA for safety, effectiveness, or quality.

Branded List Prices Without Insurance

For reference, here's what the major branded GLP-1 medications list for at their starting dose, without insurance:

• Ozempic® (0.25 mg starting dose) — from about $1,392/month.
• Mounjaro® (2.5 mg starting dose) — from about $1,505/month.
• Zepbound® (2.5 mg starting dose) — from about $1,512/month.
• Wegovy® (0.25 mg starting dose) — from about $1,856/month.

Manufacturer savings cards and self-pay programs can reduce these for eligible patients — check the current terms directly on the manufacturer's site before assuming a price.

Where The GLP Doctor Fits

The GLP Doctor's compounded programs start well below those branded list prices: $149/month for semaglutide, $199/month for tirzepatide, and $259/month for semaglutide oral tablets — flat, regardless of dose. That's a meaningfully lower cash-pay starting point for patients without insurance coverage, though it's worth being clear about why: compounded medications are a different regulatory category from the branded product, prescribed only where a licensed provider documents an individualized clinical reason, not simply because they cost less.

Why the Bill Jumps as You Titrate

Titration is the mechanism. Most people don't start on a maintenance dose — they build up over weeks or months under a prescriber's supervision. On a dose-tiered program, every step up the dosing ladder is also a step up in price.

The math that felt comfortable in week one can look very different by month seven. Here's the same year, two ways, using the low and high ends of the 2026 market range as an illustration:

• Months 1–3: escalating program ~$99/month vs. The GLP Doctor's flat semaglutide rate of $149/month.
• Months 4–6: escalating program ~$225/month vs. $149/month flat.
• Months 7–12: escalating program $348/month vs. $149/month flat.
• Twelve-month total: escalating program ~$3,060 vs. $1,788 flat.

The escalating column is an illustration built from published market endpoints, not a quote from any named competitor. Your actual ladder depends on the specific program you choose — ask for it in writing before entering a card number. The GLP Doctor's flat-rate model also applies to compounded tirzepatide, at $199/month regardless of dose.

The pattern tends to hold even when the exact numbers shift: a low entry price paired with a steep dosing ladder usually beats a flat price for about a quarter, then loses for the rest of the year.

Fees That Rarely Show Up in the Ad

Ask about these five before you commit — a provider that answers plainly is telling you something good about itself:

• Membership or subscription fees charged separately from the medication
• Consultation fees for the initial evaluation, and sometimes for follow-ups
• Shipping, especially for cold-chain medications
• Lab work, where a provider requires it
• Cancellation terms — occasionally structured so you pay for a month you didn't want

What the New Oral GLP-1 Options Could Do to Pricing

Two additional oral GLP-1 products have entered the market in the past year: oral semaglutide 25 mg and orforglipron (marketed as Foundayo). More approved products generally means more competitive pressure on price over time, and cash-pay pricing tends to follow competition rather than lead it. Whether that reaches your monthly bill in 2026 or 2027 is genuinely unknown — treat any claim that it will happen on a specific timeline with skepticism.

On the compounded side, oral options already have a lower entry point: The GLP Doctor offers compounded semaglutide oral tablets starting at $259/month (0.25 mg), for patients who prefer not to inject. This sits above the injectable semaglutide price ($149/month) but is still well below typical branded oral list pricing.

Where Compounded Semaglutide and Tirzepatide Fit in 2026

Once the FDA resolves a drug shortage, 503B batch compounding of that molecule is closed off, but 503A patient-specific compounding remains lawful where a prescriber documents an individualized clinical reason the commercially available product doesn't meet — a dose that isn't commercially available, for example.

You can check current shortage status directly on the FDA Drug Shortage Database rather than relying on a point-in-time date in any single article, since shortage determinations can change.

Price is not a clinical reason. A cheaper compounded preparation is not a substitute for an approved drug on any measure the FDA has reviewed. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.

Five Questions to Ask Before You Pay

• What will I pay at every dose — not just the first one?
• Is there a membership, consultation, or lab fee on top of the medication price?
• Is shipping included, and is it cold-chain where the medication requires it?
• What happens to my price if my prescriber holds me at a lower dose for longer?
• How do I cancel, and what's the notice period?

How The GLP Doctor's Pricing Works

The GLP Doctor's compounded weight loss programs are priced flat, regardless of dose:

• Semaglutide (injection), 1 mg starting dose — $149/month.
• Tirzepatide (injection), 10 mg starting dose — $199/month.
• Semaglutide oral tablets, 0.25 mg starting dose — $259/month.

That's a fraction of what the equivalent branded medications list for without insurance — and the price doesn't change as your dose increases. Nobody on our end has an incentive to move you up a dose faster, and nobody loses if your prescriber decides you're doing well where you are — which matters most for patients who titrate slowly and are usually penalized hardest by dose-tiered billing.

The model follows the same three steps for every patient:

• Online Consultation — a licensed provider evaluates your health history and goals before anything is prescribed.
• Fast, Free Delivery — shipping is free on orders over $150, with no separate membership fee.
• Ongoing Support — dosage adjustments and continued monitoring from your care team as your treatment progresses.

Providers are licensed in all 50 states and the service is LegitScript-approved. We work exclusively with 503A-compliant compounding partners where compounded medication is clinically appropriate.

Everything here is prescription-only and follows an evaluation by a licensed provider; not everyone is eligible. Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo are trademarks of their respective owners and are named descriptively.

See what you'd pay at every dose — Start My Free Assessment →

Frequently Asked Questions

What's the cheapest legitimate route to a GLP-1 medication?

It depends on your insurance. If your plan covers weight management, that's almost always the cheapest option. If it doesn't, compare full-year totals across cash-pay programs rather than comparing month-one prices.

Does a higher dose cost more with The GLP Doctor?

No. Semaglutide stays at $149/month and tirzepatide stays at $199/month, regardless of your dose.

Will insurance cover a GLP-1 medication in 2026?

Sometimes, and less often than in prior years — employer benefit designs have tightened. Check your formulary and whether prior authorization is required.

Is compounded semaglutide legal in 2026?

503A patient-specific compounding remains legal when a licensed prescriber documents an individualized clinical reason — such as a dose that isn't commercially available. It is not legal or appropriate to prescribe a compounded version solely because it's cheaper; price alone is not a valid clinical reason.

How much is Ozempic or Wegovy without insurance in 2026?

Without insurance, Ozempic® lists from about $1,392/month and Wegovy® from about $1,856/month at their starting doses — check the manufacturer's current self-pay program directly, since list prices and savings-card terms change. Compounded semaglutide, where clinically appropriate, starts considerably lower — The GLP Doctor's program is $149/month.

Should I prepay for a year to get a discount?

Only if you're confident you'll tolerate the medication well. A meaningful share of people stop within the first three months for reasons ranging from side effects to changed circumstances, and a prepaid plan doesn't always refund cleanly.

Is compounded semaglutide really that much cheaper than branded?

At the starting dose, yes — branded Ozempic® and Wegovy® list from roughly $1,392–$1,856/month without insurance, while The GLP Doctor's compounded semaglutide program is $149/month. That gap reflects the difference between an FDA-approved manufactured product and a compounded preparation, not just a discount — compounded medications are only appropriate when a licensed prescriber documents an individualized clinical reason, and they aren't reviewed by the FDA for safety, effectiveness, or quality the way the branded product is.